BDTX - Black Diamond Therapeutics Inc
2.27
0.090 3.965%
Share volume: 805,365
Last Updated: 03-10-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$2.18
0.09
0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-06-2024 | 11-05-2024 | 03-06-2025 | 05-12-2025 | 11-06-2025 | |
| Cash flow financing | 4.130 M | 21.378 M | -252.000 K | 291.000 K | 32.000 K | 134.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 134.000 K | |
| Cash flow | -30.803 M | 7.392 M | -9.382 M | 13.005 M | 61.989 M | 874.000 K | |
| Net income | -18.225 M | -19.909 M | -15.557 M | -15.985 M | 56.542 M | -8.498 M | |
| Depreciation | 86.000 K | 86.000 K | 86.000 K | 85.000 K | 87.000 K | 86.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -13.734 M | 740.000 K | 2.193 M | 27.769 M | 8.547 M | 8.590 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | -48.000 K | -8.000 K | -13.000 K | -1.000 K | |
| Cash Change | -30.803 M | 7.392 M | -9.382 M | 13.005 M | 61.989 M | 874.000 K |